216
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Maternal serum Netrin-1 levels as a new biomarker of preeclampsia

, , , , , , , , & show all
Pages 1072-1074 | Received 03 Mar 2016, Accepted 10 Jun 2016, Published online: 04 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Morteza Ghasemnejad Berenji, Hojjat Ghasemnejad Berenji, Sarvin Pashapour & Sonia Sadeghpour. (2022) Serum Netrin-1 and Urinary KIM-1 levels as potential biomarkers for the diagnosis of early preeclampsia. Journal of Obstetrics and Gynaecology 42:4, pages 636-640.
Read now

Articles from other publishers (3)

Zekiye Soykan Sert. (2022) The role of serum netrin-1 level in the detection of early-onset preeclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology 270, pages 164-168.
Crossref
Ebrahim M. Yimer, Kaleab Alemayehu Zewdie & Hailemichael Zeru Hishe. (2018) Netrin as a Novel Biomarker and Its Therapeutic Implications in Diabetes Mellitus and Diabetes-Associated Complications. Journal of Diabetes Research 2018, pages 1-20.
Crossref
Serdar Gülşen, Yasemin Çekmez, İpek Ulu, Şebnem Garip, Fatma Tutku Aksoy, Simge Bagcı Türkmen, Gülden Gök & Gürkan Kıran. (2017) Investigation of the relation of maternal serum endocan levels to preeclampsia presence and severity. LaboratoriumsMedizin 41:3, pages 117-121.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.